| Literature DB >> 29617424 |
Omid Rasouli1,2, Ottar Vasseljen2, Egil A Fors2, Håvard W Lorås1, Ann-Katrin Stensdotter1.
Abstract
As many similar symptoms are reported in fibromyalgia (FM) and chronic fatigue syndrome (CFS), underlying defcits may potentially also be similar. Postural disequilibrium reported in both conditions may thus be explained by similar deviations in postural control strategies. 75 females (25/group FM, CFS and control, age 19-49 years) performed 60 s of quiet standing on a force platform in each of three conditions: 1) firm surface with vision, 2) firm surface without vision and, 3) compliant surface with vision. Migration of center of pressure was decomposed into a slow and a fast component denoting postural sway and lateral forces controlling postural sway, analyzed in the time and frequency domains. Main effects of group for the antero-posterior (AP) and medio-lateral (ML) directions showed that patients displayed larger amplitudes (AP, p = 0.002; ML, p = 0.021) and lower frequencies (AP, p < 0.001; ML, p < 0.001) for the slow component, as well as for the fast component (amplitudes: AP, p = 0.010; ML, p = 0.001 and frequencies: AP, p = 0.001; ML, p = 0.029) compared to controls. Post hoc analyses showed no significant differences between patient groups. In conclusion, both the CFS- and the FM-group differed from the control group. Larger postural sway and insufficient control was found in patients compared to controls, with no significant differences between the two patient groups.Entities:
Mesh:
Year: 2018 PMID: 29617424 PMCID: PMC5884530 DOI: 10.1371/journal.pone.0195111
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the participants in each group.
| Variables | CG (N = 25) | CFS (N = 25) | FM (N = 25) |
|---|---|---|---|
| 34.4 (7.9) | 34.0 (8.9) | 38.6 (8.0) | |
| 68.0 (9.8) | 71.6 (12.9) | 75.4 (14.3) | |
| 167.2 (7.1) | 169.1 (5.4) | 168.5 (6.0) | |
| 24.3 (3.5) | 25.2 (5.1) | 26.5 (4.5) | |
| 16.1 (2.3) | 13.4 (2.5) | 13.5 (2.2) | |
| 0.08 (0.28) | 1 (1.16) | 3.7 (1.8) | |
| 0.6 (0.8) | 3 (1.8) | 3.2 (2.2) | |
| 5.8 (5.7) | 25.4 (3.8) | 21.1 (5) | |
| - | - | 56.9 (13) |
Means (SD). CG: Control group, CFS: Chronic Fatigue Syndrome, FM: Fibromyalgia, FIQ: Fibromyalgia Impact Questionnaire.
*Level of pain and fatigue on the day of testing registered upon arrival to the lab using Numeric Rating Scale (0 no pain -10 worst pain).
** Level of fatigue using the continuous Chalder Fatigue Scale (0 no fatigue -33 most severe fatigue).
Post-hoc comparisons for the significant factors.
| Variable | Group | Post-hoc | Mean difference |
|---|---|---|---|
| F (2,72) = 59.2 | CG-CFS | -0.9 | |
| CG-FM | -3.6 | ||
| CFS-FM | -2.7 | ||
| F (2,72) = 18.9 | CG-CFS | -2.4 | |
| CG-FM | -2.6 | ||
| F (2,72) = 108.9 | CG-CFS | -19.5 | |
| CG-FM | -15.3 | ||
| CFS-FM | 4.2 | ||
| F (2,72) = 10.7 | CG-CFS | 2.7 | |
| CG-FM | 2.5 |
CFS: Chronic Fatigue Syndrome, FM: Fibromyalgia, CG: Control group.
* = p<0.05,
** = p<0.001
Fig 1Estimated group means and SD for the slow component for each condition and both antero-posterior and medio-lateral directions during quiet standing on firm surface with vision (VS), on firm surface with no vision (NV), and on compliant surface with vision (VSc) for Control group (CG), Chronic Fatigue Syndrome (CFS), and for Fibromyalgia (FM).
Interactions, main effects of condition and group with post hoc comparisons for migration of center of pressure for the slow and fast components during three conditions of quiet standing on a force platform on a firm surface with and without vision, and on a compliant surface with vision.
| Variable | Group*Condition | Condition | Group | Post hoc | |
|---|---|---|---|---|---|
| F(3.5,124.5) = 1.27 | |||||
| F(2.9,104.1) = 1.83 | |||||
| F(4,144) = 0.961 | F(2,144) = 0.005 | ||||
| F(4,144) = 1.69 | |||||
| F(2.9,104.4) = 0.47 | |||||
| F(4,144) = 0.82 | F(2,144) = 2.95 | ||||
| F(4,144) = 0.78 | F(2,144) = 2.86 |
Amp: Amplitude (mm), F: Frequency (Hz), AP: Antero-posterior, ML: Medio-lateral. CFS: Chronic Fatigue Syndrome, FM: Fibromyalgia, CG: Control group. Bold text = significant. Post hoc: only significant comparisons are listed. Effect size: η2 (small = 0.01; medium = 0.06; large = 0.14).
Fig 2Estimated group means and SD for the fast component for each condition and both antero-posterior and medio-lateral directions during quiet standing on firm surface with vision (VS), on firm surface with no vision (NV), and on compliant surface with vision (VSc) for Control group (CG), Chronic Fatigue Syndrome (CFS), and for Fibromyalgia (FM).